1. Tareev EM. Klinicheskaya nefrologiya. Meditsina, M, 1983; 329340
2. Tareeva IE, red. Nefrologiya: rukovodstvo dlya vrachei. V 2kh t. Meditsina, M, 1995; 300314
3. Vassalli P, McCluskey HT. The coagulation process and glomerular disease. Am J Med 1965; 39 (2): 179183
4. Humair L, Kwaan RC, Potter BV. The role of fibrinogen in renal disease. II. Effect of anticoagulants and urokinase on experimental lesions in mice. J Lab Clin Med 1969; 74 (1); 7278
5. Humair L, Potter BV, Kwaan HC. The role of fibrinogen in renal disease. I. Production of experimental lesions in mice. J Lab Clin Med 1969; 74 (2): 6071
6. Ambarova LI, Slonskaya VT, Beshlei VI. Vliyanie ge parina na techenie eksperimental'nogo glomerulonefrita. V: Sistema svertyvaniya krovi i fibrinoliz. Saratov, 1975; t.1; 339340
7. Monastyrskii VA, Dudok VV, Dzis' EI. Mekhanizm sanogennogo deistviya plazmina pri nefroticheskom nefrite. V: Protivotromboticheskaya terapiya v klinicheskoi praktike. Novoe v terapii, diagnostike, lechenii. M., 1982; 8485
8. Hainer JW, Sherrard DJ, Swan SK et al. Intravenous and subcutaneous weightbased dosing of the low molecular weight heparin tinzaparin (Innohep) in endstage renal disease patients undergoing chronic hemodialysis. Am J Kidney Dis 2002; 40 (3): 531538
9. Sokratov NV, Slesarev OV. Sistema agregatnogo so stoyaniya krovi, mekhanizmy ee regulyatsii i korrektsii pri patologii pochek. Materialy 3 i Vsesoyuznoi konferentsii «Protivotromboticheskaya terapiya v klinicheskoi praktike. Novoe v teorii, diagnostike, lechenii». M., 1986; 120121
10. Sokratov NV. Transformatsiya urovnei statsionarnogo sostoyaniya sistemy gemostaza pri zabolevaniyakh po chek. Monografiya. Pressa, OGPU, Orenburg, 2003; 290310
11. Barkagan ZS, Lychev VG, Byshevskii KM. Sovremennye problemy diagnostiki i patogeneticheskoi terapii sindroma disseminirovannogo vnutrisosudistogo svertyvaniya krovi. Ter arkh 1979; (9): 1118
12. Lychev VG. Diagnostika i lechenie disseminirovannogo vnutrisosudistogo svertyvaniya krovi. NGMA Nizhnii Novgorod, 1998; 120134
13. Sokratov NV. «Sposob lecheniya zabolevanii pochek». Patent na izobretenie (deistvuyushchii s 5 maya 1999 g.). Izobreteniya. Poleznye modeli. Ofitsial'nyi byulleten' Rossiiskogo agentstva po patentam i tovarnym znakam. M., 2002; (15) 210
14. Sokratov NV. Sushchestvuet li disseminirovannoe vnutrisosudistoe svertyvanie krovi (DVS ili TGSsind rom) pri patalogii pochek? Vestnik Orenburgskogo gosped universiteta, 2003; (3): 1734.
15. Barkagan ZS, Glazunova GA, Lychev VG. Al'ternativnye puti svertyvaniya krovi kak prichina neeffektivnosti geparinoterapii. V: Protivotromboticheskaya terapiya v klinicheskoi praktike. Novoe v teorii, diagnostike, lechenii. M., 1982; 5556
16. Lychev VG. Diagnostika i lechenie disseminirovannogo vnutrisosudistogo svertyvaniya krovi. Meditsina, M., 1993; 128134
17. Bazarova MA, Vorob'ev AI, Barkagan ZS i dr. Rukovodstvo po klinicheskoi laboratornoi diagnostike. Uchebnoe posobie. Vysshaya shkola, Kiev, 1991
18. Momot AP. Membrannaya aktivatsiya svertyvaniya krovi, markery trombinemii pri DVS sindrome (razrabotka i aprobatsiya novykh diagnosticheskikh testov). Avto ref. diss. … dokt. med. nauk, Barnaul, 1997
19. Kudryashov BA, Lyapina LA. Metod opredeleniya aktivnosti fiziologicheskikh rastvoritelei nestabiliziro vannogo fibrina. Labor delo 1971; (6): 326329
20. Lyapina LA. Kompleksy geparina s trombogennymi belkami kak gumoral'nye agenty protivosvertyvayushchei sistemy krovi. Avtoref. dis. … kand. biol. nauk, M., 1968